- Home
- WBA
as 07-26-2024 4:00pm EST
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
| Founded: | 1901 | Country: | United States |
| Employees: | N/A | City: | DEERFIELD |
| Market Cap: | 9.3B | IPO Year: | N/A |
| Target Price: | $16.86 | AVG Volume (30 days): | 25.8M |
| Analyst Decision: | Hold | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -6.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.69 - $30.86 | Next Earning Date: | 06-27-2024 |
| Revenue: | $145,532,000,000 | Revenue Growth: | 6.92% |
| Revenue Growth (this year): | 5.5% | Revenue Growth (next year): | 3.62% |
Stock Insider Trading Activity of Walgreens Boots Alliance Inc. (WBA)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bhandari Inderpal S | WBA | Director | Apr 11 '24 | Buy | $18.05 | 3,000 | $54,150.00 | 3,000 | SEC Form 4 |
| Mahajan Manmohan | WBA | EVP and Global CFO | Apr 2 '24 | Buy | $19.38 | 6,000 | $116,280.00 | 166,969 | SEC Form 4 |
| Walgreens Boots Alliance, Inc. | WBA | 10% Owner | Feb 7 '24 | Sell | $235.41 | 4,212,395 | $991,639,906.95 | 26,277,561 | SEC Form 4 |
| JARRETT VALERIE B | WBA | Director | Jan 29 '24 | Buy | $22.44 | 4,456 | $99,992.64 | 4,456 | SEC Form 4 |
| SCHLICHTING NANCY M | WBA | Director | Jan 16 '24 | Sell | $23.05 | 15,209 | $350,567.45 | 0 | SEC Form 4 |
| WENTWORTH TIMOTHY C | WBA | Chief Executive Officer | Jan 5 '24 | Buy | $24.22 | 10,000 | $242,220.00 | 585,122 | SEC Form 4 |
| Gates Richard P. | WBA | SVP, Chief Pharmacy Officer | Nov 10 '23 | Sell | $20.45 | 1,000 | $20,450.00 | 73,929 | SEC Form 4 |
Latest Walgreens Boots Alliance Inc. News
WBA Breaking Stock News: Dive into WBA Ticker-Specific Updates for Smart Investing
MarketWatch
a day ago
The stock market’s cruel summer is about to get much worse
Bloomberg
a day ago
JPMorgan Sounds Out Investors on Potential Walgreens Junk Bond
MT Newswires
a day ago
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11
Argus Research
2 days ago
Analyst Report: Walgreens Boots Alliance Inc
Argus Research
2 days ago
Market Digest: FI, GOOGL, ODFL, RF, STX, WBA, ZION
Motley Fool
2 days ago
2 Ultra-High-Yield Dividend Stocks Down More Than 50% Over the Past Year: Are They Dirt-Cheap Buys Now?
Thomson Reuters StreetEvents
2 days ago
Q2 2024 Agree Realty Corp Earnings Call
Motley Fool
3 days ago
5 Things Walgreens Boots Alliance Can Do to Turn Things Around
Compare WBA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WBA Walgreens Boots Alliance Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.